| Date Filed | Type | Description |
| 08/22/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on AN2 Therapeutics, Inc.|
Txns:
| Bought 1,777,778 shares
@ $9, valued at
$16M
|
|
| 08/09/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Granted 45,000 options to buy
@ $4.58, valued at
$206.1k
|
|
| 08/09/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (Former 10% owners and Director) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Unknown transaction of 7,070,205 shares
@ $0
Unknown transaction of 786,407 shares
@ $0
Disposed/sold 21,250 options to buy
@ $14.98, valued at
$318.3k
|
|
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Bought 935,850 shares
@ $5, valued at
$4.7M
|
|
| 06/28/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $6.5, valued at
$260k
|
|
| 06/16/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $13.22, valued at
$165.3k
|
|
| 06/09/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Nkarta, Inc.|
Txns:
| Granted 22,500 options to buy
@ $4.86, valued at
$109.4k
|
|
| 06/08/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Aerovate Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $16.3, valued at
$203.8k
|
|
| 06/08/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 9,650 options to buy
@ $6.37, valued at
$61.5k
|
|
| 06/08/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Granted 17,000 options to buy
@ $9.89, valued at
$168.1k
|
|
| 06/08/2023 |
4
| Shah Rajeev M. (10% Owner) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Unknown transaction of 5,914,252 shares
@ $0.91, valued at
$5.4M
Disposed/sold 10,000 options to buy
@ $26.99, valued at
$269.9k
Disposed/sold 20,000 options to buy
@ $4.6, valued at
$92k
Disposed/sold 30,000 options to buy
@ $3.46, valued at
$103.8k
|
|
| 06/02/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Granted 30,000 options to buy
@ $4.79, valued at
$143.7k
|
|
| 06/02/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Granted 14,500 options to buy
@ $14.47, valued at
$209.8k
|
|
| 05/17/2023 |
4
| Shah Rajeev M. (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 16,500 options to buy
@ $1.82, valued at
$30k
|
|
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/27/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (Former 10% owner) has filed a Form 4 on Enliven Therapeutics, Inc.|
Txns:
| Granted 1,152,460 shares
@ $0 |
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2023 |
3
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 3 on Mineralys Therapeutics, Inc. |
| 01/24/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Bought 1,923,076 shares
@ $13, valued at
$25M
|
|
| 01/10/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Bought 1,853,000 shares
@ $2.21, valued at
$4.1M
|
|
| 01/06/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Bought 122,334 shares
@ $7.0276, valued at
$859.7k
Bought 58,369 shares
@ $7.7968, valued at
$455.1k
|
|
| 01/05/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on IMARA Inc.|
Txns:
| Bought 629,297 shares
@ $3.9982, valued at
$2.5M
|
|
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|